Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

Cited In for PubMed (Select 22493325)

1.

Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study.

Raffetti E, Albini L, Gotti D, Segala D, Maggiolo F, di Filippo E, Saracino A, Ladisa N, Lapadula G, Fornabaio C, Castelnuovo F, Casari S, Fabbiani M, Pierotti P, Donato F, Quiros-Roldan E; MASTER Cohort.

BMC Public Health. 2015 Mar 12;15:235. doi: 10.1186/s12889-015-1565-0.

2.

Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients.

Suchindran S, Regan S, Meigs JB, Grinspoon SK, Triant VA.

Open Forum Infect Dis. 2014 Oct 20;1(3):ofu076. doi: 10.1093/ofid/ofu076. eCollection 2014 Dec.

3.

Factors associated with cancer incidence and with all-cause mortality after cancer diagnosis among human immunodeficiency virus-infected persons during the combination antiretroviral therapy era.

Patel P, Armon C, Chmiel JS, Brooks JT, Buchacz K, Wood K, Novak RM.

Open Forum Infect Dis. 2014 May 27;1(1):ofu012. doi: 10.1093/ofid/ofu012. eCollection 2014 Mar.

4.

HIV treatment outcomes among people who inject drugs in Victoria, Australia.

Walsh N, Mijch A, Watson K, Wand H, Fairley CK, McNeil J, Crofts N, Maher L.

BMC Infect Dis. 2014 Dec 19;14:707. doi: 10.1186/s12879-014-0707-9.

5.

Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.

Helleberg M, May MT, Ingle SM, Dabis F, Reiss P, Fätkenheuer G, Costagliola D, d'Arminio A, Cavassini M, Smith C, Justice AC, Gill J, Sterne JA, Obel N.

AIDS. 2015 Jan 14;29(2):221-9. doi: 10.1097/QAD.0000000000000540.

6.

The effect of adherence to guidelines for initial antiretroviral therapy on 1-year outcomes: a French cohort study.

Cotte L, Bénet T, Vanhems P, Brochier C, Perpoint T, Ferry T, Chidiac C.

BMC Infect Dis. 2014 Nov 14;14:596. doi: 10.1186/s12879-014-0596-y.

7.

High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs.

Milloy MJ, Marshall B, Kerr T, Richardson L, Hogg R, Guillemi S, Montaner JS, Wood E.

Drug Alcohol Rev. 2015 Mar;34(2):135-40. doi: 10.1111/dar.12223. Epub 2014 Nov 11.

PMID:
25389027
8.

Are HIV-infected men vulnerable to prostate cancer treatment disparities?

Murphy AB, Bhatia R, Martin IK, Klein DA, Hollowell CM, Nyame Y, Dielubanza E, Achenbach C, Kittles RA.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2009-18. doi: 10.1158/1055-9965.EPI-14-0614. Epub 2014 Jul 25.

PMID:
25063519
9.

High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting.

Slawson G, Milloy MJ, Balneaves L, Simo A, Guillemi S, Hogg R, Montaner J, Wood E, Kerr T.

AIDS Behav. 2015 Jan;19(1):120-7. doi: 10.1007/s10461-014-0847-3.

PMID:
25012624
10.

Measuring HIV-related mortality in the first decade of anti-retroviral therapy in sub-Saharan Africa.

Todd J, Slaymaker E, Zaba B, Mahy M, Byass P.

Glob Health Action. 2014 May 21;7:24787. doi: 10.3402/gha.v7.24787. eCollection 2014. No abstract available.

11.

HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.

Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, Ferre AL, Hayes TL, Somsouk M, Hsue PY, Van Natta ML, Meinert CL, Lederman MM, Hatano H, Jain V, Huang Y, Hecht FM, Martin JN, McCune JM, Moreno S, Deeks SG.

PLoS Pathog. 2014 May 15;10(5):e1004078. doi: 10.1371/journal.ppat.1004078. eCollection 2014 May.

12.

HIV and aging: emerging research issues.

Hunt PW.

Curr Opin HIV AIDS. 2014 Jul;9(4):302-8. doi: 10.1097/COH.0000000000000072. Review.

PMID:
24824891
13.

How have ART treatment programmes changed the patterns of excess mortality in people living with HIV? Estimates from four countries in East and Southern Africa.

Slaymaker E, Todd J, Marston M, Calvert C, Michael D, Nakiyingi-Miiro J, Crampin A, Lutalo T, Herbst K, Zaba B.

Glob Health Action. 2014 Apr 22;7:22789. doi: 10.3402/gha.v7.22789. eCollection 2014.

14.

Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection.

Hunt PW, Sinclair E, Rodriguez B, Shive C, Clagett B, Funderburg N, Robinson J, Huang Y, Epling L, Martin JN, Deeks SG, Meinert CL, Van Natta ML, Jabs DA, Lederman MM.

J Infect Dis. 2014 Oct 15;210(8):1228-38. doi: 10.1093/infdis/jiu238. Epub 2014 Apr 21.

PMID:
24755434
15.

Critical importance of long-term adherence to care in HIV infected patients in the cART era: new insights from Pneumocystis jirovecii pneumonia cases over 2004-2011 in the FHDH-ANRS CO4 cohort.

Denis B, Guiguet M, de Castro N, Mechaï F, Revest M, Mahamat A, Gregoire GM, Lortholary O, Costagliola D.

PLoS One. 2014 Apr 11;9(4):e94183. doi: 10.1371/journal.pone.0094183. eCollection 2014.

16.

Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era.

Lewden C, Drabo YJ, Zannou DM, Maiga MY, Minta DK, Sow PS, Akakpo J, Dabis F, Eholié SP; IeDEA West Africa Collaboration.

J Int AIDS Soc. 2014 Apr 7;17:18797. doi: 10.7448/IAS.17.1.18797. eCollection 2014.

17.

Measuring turnover of SIV DNA in resting CD4+ T cells using pyrosequencing: implications for the timing of HIV eradication therapies.

Reece JC, Martyushev A, Petravic J, Grimm A, Gooneratne S, Amaresena T, De Rose R, Loh L, Davenport MP, Kent SJ.

PLoS One. 2014 Apr 7;9(4):e93330. doi: 10.1371/journal.pone.0093330. eCollection 2014.

18.

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.

May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, Hay P, Johnson M, Palfreeman A, Gilson R, Chadwick D, Martin F, Hill T, Walsh J, Post F, Fisher M, Ainsworth J, Jose S, Leen C, Nelson M, Anderson J, Sabin C; UK Collaborative HIV Cohort (UK CHIC) Study.

AIDS. 2014 May 15;28(8):1193-202. doi: 10.1097/QAD.0000000000000243.

19.

Determinants of viremia copy-years in people with HIV/AIDS after initiation of antiretroviral therapy.

Wright ST, Hoy J, Mulhall B, Oʼconnor CC, Petoumenos K, Read T, Smith D, Woolley I, Boyd MA.

J Acquir Immune Defic Syndr. 2014 May 1;66(1):55-64. doi: 10.1097/QAI.0000000000000125.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk